Live Breaking News & Updates on Alan Horsager

Stay updated with breaking news from Alan horsager. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder Value

18.10.2022 - Warrants to Purchase Approximately 21 Million Scopus Shares Eliminated Scopus BioPharma’s Pure Play Immuno-Oncology Subsidiary, Duet BioTherapeutics, Independently Valued at $25 Million Scopus Maintains Approximately 90% Ownership Stake in Duet . ....

Marcin Kortylewski , Rodd Leeds David Waldman , Scopus Biopharma , Joshuar Lamstein , Alan Horsager , Exchange Commission , Company Form , Scopus Biopharma Inc Nasdaq , Scopus Biopharma Inc , Crescendo Communications , Duet Being Positioned , Biopharma Inc , Chief Executive Officer , Senior Scientific Advisor ,